• Chest · Mar 1995

    Retracted Publication

    Do plasma levels of circulating soluble adhesion molecules differ between surviving and nonsurviving critically ill patients?

    • J Boldt, M Wollbrück, D Kuhn, L C Linke, and G Hempelmann.
    • Department of Anesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Germany.
    • Chest. 1995 Mar 1; 107 (3): 787792787-92.

    AbstractAdhesion molecules appear to play a central role in tissue damage secondary to inflammatory response. Besides various neutrophil- and endothelial-bound adhesion molecules, soluble forms of endothelial-derived adhesion molecules have been detected in the circulating blood in recent years. They seem to be good markers of endothelial damage, but their importance in the critically ill has not been definitely elucidated yet. Plasma levels of circulating (soluble) adhesion molecules (endothelial leucocyte adhesion molecules [sELAM-1], vascular cell adhesion molecule 1 [sVCAM-1], intercellular adhesion molecule 1 [sICAM-1]) were serially measured from arterial blood samples using enzyme-linked immunosorbent assays (ELISA) in 50 consecutive patients suffering from severe trauma (injury severity score [ISS] > 25 points) or postoperative complications. Measurements were carried out on the day of admission on the intensive care unit (ICU) ("baseline" value) and during the next 5 days. Survival was defined as survival throughout the study period. The survivor group (n = 30) consisted of more patients who had sustained trauma (53%), whereas in the nonsurvivors (n = 20) more patients with postoperative complications were found (65%). On admission to ICU, septic shock was more often seen in the nonsurvivors (30%) than in the survivors (13%) and the nonsurvivors showed a slightly higher APACHE II score at baseline. At baseline, plasma levels of all three adhesion molecules were elevated beyond normal range in both groups. The sICAM-1 and sELAM-1 plasma concentrations were significantly higher in the nonsurvivors than in the survivors already at baseline. The sELAM-1 and sICAM-1 values significantly decreased in the survivors without reaching normal values. At the end of the investigation period, sVCAM-1 plasma level was within normal range in the survivors. In the nonsurvivors, all three adhesion molecules increased significantly throughout the study period (sELAM-1, from 115 +/- 31 to 158 +/- 23 ng/mL; sICAM-1, from 830 +/- 210 to 1,536 +/- 199 ng/mL; sVCAM-1, from 861 +/- 168 to 1,249 +/- 151 ng/mL). None of the other hemodynamic or laboratory variables could be correlated with the time course of adhesion molecules, except for PaO2/Pao2 ratio, which was negatively correlated with plasma levels of soluble adhesion molecules in the nonsurvivors (analysis of covariance). It is concluded that plasma levels of soluble adhesion molecules were markedly higher in nonsurviving than in surviving critically ill patients. They may possibly serve as markers of the extent of inflammatory response, of the endothelial damage in patients at risk of multiple-organ failure or both.(ABSTRACT TRUNCATED AT 400 WORDS)

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…